Specific endothelin-A receptor antagonism for the treatment of advanced prostate cancer

BJU Int. 2009 Nov;104(10):1423-5. doi: 10.1111/j.1464-410X.2009.08740.x. Epub 2009 Jul 14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials, Phase III as Topic
  • Endothelin A Receptor Antagonists*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Pyrrolidines / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Endothelin A Receptor Antagonists
  • Pyrrolidines
  • ZD4054